Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-09-29Clinical Trial Update: Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 clinical trial results for CPX-351 in adults with first-relapse Acute Myeloid Leukemia have been completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-09-27Clinical Trial Update: Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
A completed phase 1/2 trial evaluating safety and efficacy of Astarabine in acute myeloid leukemia and acute lymphoblastic leukemia.
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 2, Phase 3]
Phase 2/3 trial evaluating all-trans retinoic acid with induction and consolidation therapy plus pegfilgrastim in younger patients with newl…
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML [NA]
A terminated clinical trial in older adults with previously untreated acute myeloid leukemia evaluating vosaroxin and cytarabine; results po…
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT [Phase 2]
Phase 2 trial evaluating abatacept-based immunosuppression to prevent acute graft-versus-host disease during unrelated donor hematopoietic c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-09-14Clinical Trial Update: Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 2]
Phase II study evaluating decitabine and cytarabine in older patients with newly diagnosed acute myeloid leukemia; the trial is completed wi…
-
CLINICAL_TRIALS trial_result · 2017-09-08Clinical Trial Update: Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of clofarabine, cytarabine, and G-CSF in relapsed or refractory acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission [Phase 2]
Phase 2 trial evaluating radiolabeled BC8 antibody with busulfan and cyclophosphamide followed by donor stem cell transplant in adults with …
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome [Phase 1]
Phase 1 trial evaluating donor peripheral blood stem cell transplantation in combination with pretargeted radioimmunotherapy for patients wi…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Mismatched Donor Cells to Treat Acute Myeloid Leukemia [Phase 1]
A Phase 1 clinical trial is evaluating mismatched donor cells to treat Acute Myeloid Leukemia. The study status is currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Haploidentical NK-cell Infusion in Acute Myeloid Leukemia [Phase 1, Phase 2]
Phase 1/2 trial of haploidentical NK-cell infusion in Acute Myeloid Leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes [Phase 1]
Phase 1 study of azacitidine plus bortezomib in relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes has completed enr…
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias [Phase 1]
Phase 1 pharmacokinetic study of oral and intravenous clofarabine in high-risk myelodysplastic syndrome and acute leukemias; the trial has c…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS [Phase 1, Phase 2]
This clinical trial update describes the Phase 1/2 results for the combination of bendamustine and idarubicin in older patients with previou…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML [Phase 1]
A Phase 1 trial evaluating lenalidomide in combination with microtransplantation as post-remission therapy for acute myeloid leukemia has be…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies [Phase 1, Phase 2]
A completed Phase 1/2 study of PRI-724 in adults with advanced myeloid malignancies (acute and chronic myeloid leukemia) evaluated safety an…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Physical Activity in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy [NA]
This clinical trial update notes the completion of a study examining the effects of physical activity in older adults with acute myeloid leu…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen [Phase 1]
Phase 1 trial evaluating a targeted, dose-escalation busulfan-etoposide conditioning regimen for acute myeloid leukemia. The study status is…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies [Phase 2]
This Phase 2 randomized trial comparing haplo cord blood transplantation versus double umbilical cord blood transplantation for hematologic …
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS [Phase 1]
Phase I trial of OXi4503 for relapsed and refractory acute myeloid leukemia and myelodysplastic syndromes was terminated.
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Decitabine, Vorinostat, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]
This Phase 1 trial evaluated the safety and preliminary activity of a three-drug combination—decitabine, vorinostat, and cytarabine—in patie…
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Efficacy and Safety Study of Recombinant Human Arginase 1 in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial update on the efficacy and safety of recombinant human arginase 1 in relapsed or refractory acute myeloid leukemia; c…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
Completed clinical trial evaluating whether the final Geriatric Assessment in Haematology (GAH) score can predict tolerance to treatment in …
-
CLINICAL_TRIALS trial_result · 2017-07-24Clinical Trial Update: Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome [Phase 4]
This Phase 4 trial compares posaconazole to micafungin for preventing invasive fungal infections during neutropenia in patients receiving ch…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase I trial of cabozantinib in patients with relapsed or refractory acute myeloid leukemia has been completed.